Last updated: October 11, 2021
Sponsor: Shandong University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Helicobacter Pylori
Treatment
N/AClinical Study ID
NCT04956679
2019SDU-QILU-186
Ages > 3 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Community population over 3 years old who signed the informed consent.
- at least 2 people in the family.
- living together for at least 10 months each year in the past 5 years except child agedbelow 5.
Exclusion
Exclusion Criteria:
- PPI drugs such as esomeprazole、pantoprazole、 rabeprazole,、lansoprazole、famotidine andH2 receptor antagonists were taken within two weeks.
- antibiotics、bismuth agents or traditional Chinese medicine with antibacterial effectwere taken within four weeks
- There are other factors that researchers think are not suitable for participation
Study Design
Total Participants: 400
Study Start date:
July 10, 2021
Estimated Completion Date:
June 30, 2022
Study Description
Connect with a study center
Department of Gastroenterology,QiLu Hospital,Shandong University
Jinan, Shandong 250012
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.